摘要
目的测定原发性肝癌Ⅳ期患者黄疸出现后的生存期,并探讨其意义。方法对住院的78例因肝功能衰竭死亡的原发性肝癌Ⅳ期患者,进行黄疸出现后生存期测定。结果 AFP(甲胎蛋白)<400μg/L原发性肝癌Ⅳ期患者,黄疸出现后最长生存期4个月,最短生存期10天,中位生存期25天;AFP>400μg/L原发性肝癌Ⅳ期患者,黄疸出现后最长生存期20天,最短生存期3天,中位生存期10天。。结论 AFP>400μg/L原发性肝癌Ⅳ期患者生存期比AFP<400μg/L原发性肝癌Ⅳ期患者短。测定原发性肝癌Ⅳ期患者黄疸出现后的生存期,可预先告知患者亲属做好善后准备,并对患者进行劝慰,让其尊严离世,同时采取相应治疗及护理措施。
Objective To determinate the survival period of stage Ⅳ hepatocellular carcinoma with jaundice. Methods The survival period of 78 cases with stage Ⅳ primary liver cancer with jaundice was observed. Results The survival period of the patients＇ AFP 〈400 μg / L was 10 days to 4 months and the median survival time was 25 days. The surviv- al period of the patients＇ AFP〉400μg/L was 3 days to 20 days and the median survival time was 10 days. Conclusion AFP is an important index of the survival period of stage Ⅳ primary liver cancer with jaundice.
出处
《西部医学》
2012年第11期2112-2113,共2页
Medical Journal of West China
关键词
肝癌Ⅳ期
黄疸出现后
生存期
测定
意义
Liver cancer stage Ⅳ
Jaundice appears
Survival
Determination
Significance
